Quality of life and tumor control after short split-course chemoradiation for anal canal carcinoma

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Provencher, Sawyna ^a,b   Oehler, Christoph ^c   Lavertu, Sophie ^a   Jolicoeur, Marjory ^a   Fortin, Bernard ^a   Donath, David ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MITOMYCIN C; ANTINEOPLASTIC AGENT; MITOMYCIN;

ADULT; AGED; ANUS CARCINOMA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; DRUG INDUCED DISEASE; ELECTIVE GROIN IRRADIATION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; QUESTIONNAIRE; SKIN TOXICITY; URINARY TRACT DISEASE; UROGENITAL TRACT TOXICITY; ANUS TUMOR; FOLLOW UP; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIATION DOSE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 77952452752     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-41     Document Type: Article

References (26)

1. Nigro ND, Vaitkevicius VK, Considine B. Combine therapy for cancer of the anal canal: A preliminary report. Dis Colon Rectum 1974, 17:354-356. 10.1007/BF02586980, 4830803.
2. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997, 15:2040-2049.
3. UKCCCR Anal Cancer Trial Working Party Epidermoid anal cancer: results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 1996, 348:1049-1054. 10.1016/S0140-6736(96)03409-5, 8874455, UKCCCR Anal Cancer Trial Working Party.
4. Flam MS, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L, Murray K. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 1996, 14:2527-2539.
5. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin 2006, 56:106-130. 10.3322/canjclin.56.2.106, 16514137.
6. Bosset JF, Roelofsen F, Morgan DA, Budach V, Coucke P, Jager JJ, Steen-Banasik E, Trivière N, Stüben G, Puyraveau M, Mercier M. Shortened irradiation scheme, continous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the EORTC. Radiotherapy and Gastrointestinal Cooperative Groups. European Journal of Cancer 2003, 39:45-51. 10.1016/S0959-8049(02)00377-5, 12504657.
7. Fenger C, Frisch M, Marti MC, Parc R. Tumors of the anal canal. World Health Organization classification of tumors: pathology and genetics of tumors of the digestive system 2000, 146. Lyon: IARC Press, Hamilton SR, Aaltonen LA.
8. Papagikos M, Crane CH, Skibber J, Janjan NA, Feig B, Rodriguez-Bigas MA, Hung A, Wolff RA, Delclos M, Lin E, Cleary K. Chemoradiation for Adenocarcinoma of the Anus. Int J Radiat Oncol Biol Phys 2003, 55(3):669-78.
9. Belkacémi Y, Berger C, Poortmans P, Piel G, Zouhair A, Méric JB, Nguyen TD, Krengli M, Behrensmeier F, Allal A, De Looze D, Bernier J, Scandolaro L, Mirimanoff RO. Management of Primary Anal Canal Adenocarcinoma: A large Retrospective Study from the Rare Center Network. Int J Radiat Oncol Biol Phys 2003, 56(5):1274-83. 10.1016/S0360-3016(03)00277-3, 12873671.
10. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85(5):365-376. 10.1093/jnci/85.5.365, 8433390.
11. Gujral S, Conroy T, Fleissner C, Sezer O, King PM, Avery KN, Sylvester P, Koller M, Sprangers MA, Blazeby JM. Assessing quality of life in patients with colorectal cancer: An update of the EORTC quality of life questionnaire. European Journal of Cancer 2007, 43:1564. 10.1016/j.ejca.2007.04.005, 17521904.
12. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A. on behalf of the EORTC Quality of Life Group. The EORTC QLQ-C30 Scoring Manual 2001, European Organisation for Research and Treatment of Cancer Brussels, 3.
13. American Joint Committee on Cancer Anal cancer. AJCC Cancer staging manual 2001, 139. New York: Springer-Verlag, Greene FL, Page DL, Fleming ID, American Joint Committee on Cancer.
14. Allal AS, Sprangers MA, Laurencet F, Reymond MA, Kurtz JM. Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy. British Journal of Cancer 1999, 80(10):1588-1594. 10.1038/sj.bjc.6690567, 2363100, 10408404.
15. Jephcott CR, Paltiel C, Hay J. Quality of life after non-surgical treatment of anal carcinoma: A case control study of long-term survivors. Clinical Oncology 2004, 16:530-535. 10.1016/j.clon.2004.05.007, 15630846.
16. Oehler-Jänne C, Seifert B, Lütolf UM, Studer G, Glanzmann C, Ciernik IF. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma. Brachytherapy 2007, 6:218-226. 10.1016/j.brachy.2007.02.152, 17681244.
17. Vordermark D, Sailer M, Flentje M, Thiede A, Kölbl O. Curative-intent radiation therapy in anal carcinoma: quality of life and sphincter function. Radiotherapy and Oncology 1999, 52:239-243. 10.1016/S0167-8140(99)00096-1, 10580870.
18. Wielen G, Mulhall J, Incrocci L. Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: A critical review. Radiother Oncol 2007, 84(2):107-13. 10.1016/j.radonc.2007.07.018, 17707936.
19. Brown MW, Brooks JP, Albert PS, Poggi MM. An analysis of erectile function after intensity modulated radiation therapy for localized prostate carcinoma. Prostate Cancer Prostatic Dis 2007, 10(2):189-93. 10.1038/sj.pcan.4500938, 17189954.
20. Salama JK, Mell LK, Schomas DA, Miller RC, Devisetty K, Jani AB, Mundt AJ, Roeske JC, Liauw SL, Chmura SJ. Concurrent Chemoradiation and Intensity-Modulated Radiation Therapy for Anal Canal Cancer Patients: A Multicenter Experience. J Clin Oncol 2007, 25(29):4581-86. 10.1200/JCO.2007.12.0170, 17925552.
21. De La Rochefordière A, Pontvert D, Asselain B, Fenton J, Alapetite C, Girodet J. Radiothérapie des cancers du canal anal. Expérience de l'Institut Curie dans le traitement des aires ganglionnaires. Bull Cancer Radiother 1993, 80:391-8.
22. Grabenbauer GG, Matzel KE, Schneider IH, Meyer M, Wittekind C, Matsche B, Hohenberger W, Sauer R. Sphincter preservation with chemoradiation in anal canal carcinoma. Dis Colon Rectum 1998, 41:441-50. 10.1007/BF02235757, 9559628.
23. Tanum G, Tveit K, Karlsen KO, Hauer-Jensen M. Chemotherapy and radiation therapy for anal canal carcinoma. Survival and late morbidity. Cancer 1991, 67:2462-6. 10.1002/1097-0142(19910515)67:10<2462::AID-CNCR2820671012>3.0.CO;2-1, 2015547.
24. James R, Pointon R, Martin S. Local radiotherapy in the management of squamous carcinoma of the anus. Br J Surg 1985, 72:282-5. 10.1002/bjs.1800720411, 3986477.
25. Cummings BJ, Keane TJ, O'Sullivan B, Wong CS, Catton CN. Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 1991, 21:1115-1125.
26. Gerard JP, Chapet O, Samiei F, Morignat E, Isaac S, Paulin C, Romestaing P, Favrel V, Mornex F, Bobin JY. Management of inguinal lymph node metastases in patients with carcinoma of the anal canal. Cancer 2001, 92(1):77-84. 10.1002/1097-0142(20010701)92:1<77::AID-CNCR1294>3.0.CO;2-P, 11443612.